Company Encyclopedia
View More
name
Venus Concept
VERO.US
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing.
1.407 T
VERO.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Health Care EquipmentIndustry
Industry Ranking148/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-854.61%E
    • Profit Margin-92.76%E
    • Gross Margin64.00%A
  • Growth ScoreD
    • Revenue YoY-12.39%E
    • Net Profit YoY-8.91%C
    • Total Assets YoY-14.74%E
    • Net Assets YoY-70.51%E
  • Cash ScoreD
    • Cash Flow Margin-107.80%D
    • OCF YoY-12.39%E
  • Operating ScoreB
    • Turnover0.88B
  • Debt ScoreE
    • Gearing Ratio94.91%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Venus Concept Extends Bridge Loan Maturity and Secures Liquidity Waivers in Latest Financing Amendment

    Venus Concept Inc. has amended its corporate financing agreements, extending the maturity date of its Bridge Loan to December 31, 2025, and securing waivers for certain liquidity requirements. The company entered a Consent Agreement with Madryn Health Partners, allowing cash interest payments to be applied to the principal balance. The Bridge Loan, established in April 2024, offers up to $28.2 million at a 12% interest rate. This information was published via EDGAR by Venus Concept Inc. and is for informational purposes only.

    Reuters·
    US
    VERO
    +7.18%
    Reuters·
    US
    VERO
    +7.18%

    Venus Concept Faces Mixed Fortunes in Earnings Call

    Venus Concept's Q3 earnings call revealed mixed results. Positive developments include the launch of Venus Nova and balance sheet improvements. However, challenges persist with declining revenue, increased losses, and issues in the Venus Hair business. The company reported an 8% revenue decline and a widened net loss of $22.6 million. Despite these challenges, Venus Concept anticipates growth in Q4, driven by new product launches and strategic financial efforts.

    Tip Ranks·
    US
    VERO
    +7.18%
    Tip Ranks·
    US
    VERO
    +7.18%

    Bitfarms shares are trading lower after the company reported worse-than-expected Q3 EPS results.

    benzinga_article·
    US
    BITF
    -0.32%
    benzinga_article·
    US
    BITF
    -0.32%

    Venus Concept Announces Third Quarter 2025 Financial Results

    TORONTO, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- Venus Concept Inc. ( "Venus Concept" or the "Company" ) ( NASDAQ: VERO ) , a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2025.

    GlobeNewswire·
    US
    VERO
    +7.18%
    GlobeNewswire·
    US
    VERO
    +7.18%

    Venus Concept Gains FDA Clearance for Venus Nova

    Venus Concept (VERO) received FDA 510(k) clearance for its new multi-application platform, Venus Nova, on November 10, 2025. This is part of the company's strategy to stabilize and grow amidst challenging market conditions. Despite a decline in Q3 2025 revenue, the company reported stabilization in Energy Based Device revenues and executed debt-to-equity exchanges. Venus Concept is also working to sell its Venus Hair Business. Analysts rate VERO stock as Hold with a $2.00 price target, while TipRanks' AI Analyst rates it Neutral due to poor financial performance.

    Tip Ranks·
    US
    VERO
    +7.18%
    Tip Ranks·
    US
    VERO
    +7.18%
    © 2025 Longbridge｜Disclaimer